https://doi.org/10.1001/jamaoncol.2023.2150
R
R. Rosell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
244
Papers
3.5K
Citations
23
h-index
38
i10-index
R. Rosell is an academic researcher from Instituto Oncológico Dr. Rosell. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Lung Cancer Research Studies. The author has an h-index of 23, co-authored 208 publications.
Papers by this author
worksEfficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast Cancer
2023 · JAMA Oncology · 29 citations
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
2023 · Critical Reviews in Oncology/Hematology · 26 citations
https://doi.org/10.1016/j.critrevonc.2023.104228
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
2024 · Cell Communication and Signaling · 12 citations
https://doi.org/10.1186/s12964-024-01667-x
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors
2022 · ESMO Open · 9 citations
https://doi.org/10.1016/j.esmoop.2022.100500
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat